Abdominal Pain and Anxious or Depressed State Are Independently Associated With Weight Loss in Inflammatory Bowel Disease
Journal: 2020/July - Crohns Colitis 360
Abstract:
Background: Many factors impact nutritional status in inflammatory bowel disease (IBD). We undertook this study to evaluate the potential role that abdominal pain has on weight loss and dietary behavior in IBD.
Methods: This is a retrospective cohort study utilizing data from an IBD registry at our institution between January 1, 2015 and August 31, 2018. Pain scores and nutritional outcomes were derived from validated questionnaires while key associated clinical data were derived from the medical record.
Results: Three hundred and three patients (154 females; 206 Crohn's disease) were included in this study. Ninety-six patients (31.7%) had experienced a 6-lb or greater weight loss in the prior month. On multivariate analysis, abdominal pain and anxious/depressed state were independently associated with weight loss, while female gender and NSAID use were inversely associated with weight loss (P < 0.05). IBD patients with abdominal pain also reported significantly poorer dietary behavior than those without this symptom.
Conclusions: Abdominal pain is more likely to result in negative dietary outcomes and independently associated with weight loss in IBD. IBD providers should screen for malnutrition when patients report abdominal pain.
Keywords: abdominal pain; diet; inflammatory bowel disease; nutritional outcomes; weight loss.
Relations:
Content
References
(50)
Diseases
(3)
Conditions
(2)
Processes
(1)
Similar articles
Articles by the same authors
Discussion board
Crohns Colitis 360 2(2): otaa047

Abdominal Pain and Anxious or Depressed State Are Independently Associated With Weight Loss in Inflammatory Bowel Disease

Division of Gastroenterology &amp; Hepatology, Department of Medicine, Penn State College of Medicine, Hershey, PA, USA
Department of Medicine, Penn State College of Medicine, Hershey, PA, USA
Penn State College of Medicine, Hershey, PA, USA
Division of Colorectal Surgery, Department of Surgery, Penn State College of Medicine, Hershey, PA, USA
Matthew Coates: ude.usp.htlaehtetatsnnep@setaocm
Address correspondence to: Matthew D. Coates, MD, PhD, Division of Gastroenterology &amp; Hepatology, Penn State College of Medicine, 500 University Drive, HU33, Hershey, PA 17033 (ude.usp.htlaehtetatsnnep@setaocm)
Received 2020 Apr 23
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

Abstract

Background

Many factors impact nutritional status in inflammatory bowel disease (IBD). We undertook this study to evaluate the potential role that abdominal pain has on weight loss and dietary behavior in IBD.

Methods

This is a retrospective cohort study utilizing data from an IBD registry at our institution between January 1, 2015 and August 31, 2018. Pain scores and nutritional outcomes were derived from validated questionnaires while key associated clinical data were derived from the medical record.

Results

Three hundred and three patients (154 females; 206 Crohn’s disease) were included in this study. Ninety-six patients (31.7%) had experienced a 6-lb or greater weight loss in the prior month. On multivariate analysis, abdominal pain and anxious/depressed state were independently associated with weight loss, while female gender and NSAID use were inversely associated with weight loss (P < 0.05). IBD patients with abdominal pain also reported significantly poorer dietary behavior than those without this symptom.

Conclusions

Abdominal pain is more likely to result in negative dietary outcomes and independently associated with weight loss in IBD. IBD providers should screen for malnutrition when patients report abdominal pain.

Keywords: abdominal pain, diet, weight loss, nutritional outcomes, inflammatory bowel disease
Click here for additional data file.(306K, docx)Click here for additional data file.(13K, docx)Click here for additional data file.(13K, docx)

References

  • 1. Singh S, Blanchard A, Walker JR, et al. Common symptoms and stressors among individuals with inflammatory Bowel diseases. Clin Gastroenterol Hepatol. 2011;9:769–775. [[PubMed][Google Scholar]
  • 2. Farmer RG, Hawk WA, Turnbull RB Jr Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology. 1975;68:627–635. [[PubMed][Google Scholar]
  • 3. Mekhjian HS, Switz DM, Melnyk CS, et al. Clinical features and natural history of Crohn’s disease. Gastroenterology. 1979;77:898–906. [[PubMed][Google Scholar]
  • 4. Harries AD, Heatley RV Nutritional disturbances in Crohn’s disease. Postgrad Med J. 1983;59:690–697. [Google Scholar]
  • 5. Gassull MA, Cabré E Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2001;4:561–569. [[PubMed][Google Scholar]
  • 6. Massironi S, Rossi RE, Cavalcoli FA, et al. Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches. Clin Nutr. 2013;32:904–910. [[PubMed][Google Scholar]
  • 7. Kilby K, Mathias H, Boisvenue L, et al. Micronutrient absorption and related outcomes in people with inflammatory Bowel disease: a review. Nutrients. 2019;11:1388. [Google Scholar]
  • 8. Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer RJ Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998;67:919–926. [[PubMed][Google Scholar]
  • 9. Lanfranchi GA, Brignola C, Campieri M, et al. Assessment of nutritional status in Crohn’s disease in remission or low activity. Hepatogastroenterology. 1984;31:129–132. [[PubMed][Google Scholar]
  • 10. Gallagher HJ, Daly JM Malnutrition, injury, and the host immune response: nutrient substitution. Curr Opin Gen Surg. 1993:92–104. [[PubMed][Google Scholar]
  • 11. Lomer MC. Dietary and nutritional considerations for inflammatory bowel disease. Proc Nutr Soc. 2011;70:329–335. [[PubMed]
  • 12. Srinath AI, Goyal A, Zimmerman LA, et al. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:1329–1340. [Google Scholar]
  • 13. Ghosh S, Mitchell R Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007;1:10–20. [[PubMed][Google Scholar]
  • 14. Bielefeldt K, Davis B, Binion DG Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:778–788. [Google Scholar]
  • 15. Coates MD, Lahoti M, Binion DG, et al. Abdominal pain in ulcerative colitis. Inflamm Bowel Dis. 2013;19:2207–2214. [Google Scholar]
  • 16. Regueiro M, Velayos F, Greer JB, et al. American gastroenterological association institute technical review on the management of Crohn’s disease after surgical resection. Gastroenterology. 2017;152:277–295.e3. [[PubMed][Google Scholar]
  • 17. Szigethy E. Pain Management in patients with inflammatory Bowel disease. Gastroenterol Hepatol (N Y). 2018;14:53–56.
  • 18. Schirbel A, Reichert A, Roll S, et al. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol. 2010;16:3168–3177. [Google Scholar]
  • 19. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804–810. [[PubMed][Google Scholar]
  • 20. Irvine EJ, Zhou Q, Thompson AK The short inflammatory Bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn’s relapse prevention trial. Am J Gastroenterol. 1996;91:1571–1578. [[PubMed][Google Scholar]
  • 21. Lamb CA, Kennedy NA, Raine T, et al; IBD guidelines eDelphi consensus group British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1–s106. [Google Scholar]
  • 22. Wilson MM, Thomas DR, Rubenstein LZ, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82:1074–1081. [[PubMed][Google Scholar]
  • 23. Kruizenga HM, Seidell JC, de Vet HC, et al. Development and validation of a hospital screening tool for malnutrition: the short nutritional assessment questionnaire (SNAQ). Clin Nutr. 2005;24:75–82. [[PubMed][Google Scholar]
  • 24. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A. [[PubMed][Google Scholar]
  • 25. Satsangi J, Silverberg MS, Vermeire S, Colombel JF The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753. [Google Scholar]
  • 26. Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. [[PubMed][Google Scholar]
  • 27. Yamamoto-Furusho JK, Sarmiento-Aguilar A, García-Alanis M, et al. Hospital Anxiety and Depression Scale (HADS): validation in mexican patients with inflammatory Bowel disease. Gastroenterol Hepatol. 2018;41:477–482. [[PubMed][Google Scholar]
  • 28. Bjelland I, Dahl AA, Haug TT, Neckelmann D The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77. [[PubMed][Google Scholar]
  • 29. Honarmand K, Feinstein A Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler. 2009;15:1518–1524. [[PubMed][Google Scholar]
  • 30. Navabi S, Gorrepati VS, Yadav S, et al. Influences and impact of anxiety and depression in the setting of inflammatory Bowel disease. Inflamm Bowel Dis. 2018;24:2303–2308. [[PubMed][Google Scholar]
  • 31. Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29.
  • 32. Fisher MM, Rosen DS, Ornstein RM, et al. Characteristics of avoidant/restrictive food intake disorder in children and adolescents: a “new disorder” in DSM-5. J Adolesc Health. 2014;55:49–52. [[PubMed][Google Scholar]
  • 33. Norris ML, Robinson A, Obeid N, et al. Exploring avoidant/restrictive food intake disorder in eating disordered patients: a descriptive study. Int J Eat Disord. 2014;47:495–499. [[PubMed][Google Scholar]
  • 34. Mills JG, Thomas SJ, Larkin TA, et al. Problematic eating behaviours, changes in appetite, and weight gain in major depressive disorder: the role of leptin. J Affect Disord. 2018;240:137–145. [[PubMed][Google Scholar]
  • 35. Colman I, Kingsbury M, Sucha E, et al. Depressive and anxious symptoms and 20-year mortality: evidence from the Stirling COUNTY study. Depress Anxiety. 2018;35:638–647. [Google Scholar]
  • 36. Rosenblatt E, Kane S Sex-specific issues in inflammatory Bowel disease. Gastroenterol Hepatol (N Y). 2015;11:592–601. [Google Scholar]
  • 37. Christian KE, Russman KM, Rajan DP, et al. Gender differences and other factors associated with weight gain following initiation of infliximab: a post Hoc analysis of clinical trials. Inflamm Bowel Dis. 2020;26:125–131. [[PubMed][Google Scholar]
  • 38. Mendall MA, Jensen CB, Sørensen TIA, et al. Body mass index in young men and risk of inflammatory bowel disease through adult life: a population-based Danish cohort study. Sci Rep. 2019;9:6360. [Google Scholar]
  • 39. Singh S, Graff LA, Bernstein CN Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol. 2009;104:1298–313; quiz 1314. [[PubMed][Google Scholar]
  • 40. Long MD, Kappelman MD, Martin CF, et al. Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory Bowel disease. J Clin Gastroenterol. 2016;50:152–156. [Google Scholar]
  • 41. Maxwell MA, Cole DA Weight change and appetite disturbance as symptoms of adolescent depression: toward an integrative biopsychosocial model. Clin Psychol Rev. 2009;29:260–273. [[PubMed][Google Scholar]
  • 42. Jackson SE, Steptoe A, Beeken RJ, et al. Psychological changes following weight loss in overweight and obese adults: a prospective cohort study. Plos One. 2014;9:e104552. [Google Scholar]
  • 43. Skrovanek S, DiGuilio K, Bailey R, et al. Zinc and gastrointestinal disease. World J Gastrointest Pathophysiol. 2014;5:496–513. [Google Scholar]
  • 44. Mouli VP, Ananthakrishnan AN Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39:125–136. [Google Scholar]
  • 45. Doulberis M, Papaefthymiou A, Kountouras J, et al. Vitamin D deficiency and unclear abdominal pain in patients from low- and middle-income countries. Int J Environ Res Public Health. 2019;16:4607. [Google Scholar]
  • 46. Vidarsdottir JB, Johannsdottir SE, Thorsdottir I, et al. A cross-sectional study on nutrient intake and -status in inflammatory bowel disease patients. Nutr J. 2016;15:61. [Google Scholar]
  • 47. Czuber-Dochan W, Morgan M, Hughes LD, et al. Perceptions and psychosocial impact of food, nutrition, eating and drinking in people with inflammatory bowel disease: a qualitative investigation of food-related quality of life. J Hum Nutr Diet. 2020;33:115–127. [[PubMed][Google Scholar]
  • 48. Wardle RA, Thapaliya G, Nowak A, et al. An examination of appetite and disordered eating in active Crohn’s disease. J Crohns Colitis. 2018;12:819–825. [[PubMed][Google Scholar]
  • 49. de Vries JHM, Dijkhuizen M, Tap P, Witteman BJM Patient’s dietary beliefs and behaviours in inflammatory Bowel disease. Dig Dis. 2019;37:131–139. [Google Scholar]
  • 50. Tomar SK, Kedia S, Upadhyay AD, et al. Impact of dietary beliefs and practices on patients with inflammatory bowel disease: an observational study from India. JGH Open. 2017;1:15–21. [Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.